nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—KCNMA1—kidney cancer	0.346	0.468	CbGaD
Hydroflumethiazide—CA9—kidney cancer	0.208	0.28	CbGaD
Hydroflumethiazide—CA2—kidney cancer	0.187	0.252	CbGaD
Hydroflumethiazide—SLC12A3—collecting duct of renal tubule—kidney cancer	0.0187	0.201	CbGeAlD
Hydroflumethiazide—SLC12A1—collecting duct of renal tubule—kidney cancer	0.0142	0.153	CbGeAlD
Hydroflumethiazide—SLC12A3—nephron—kidney cancer	0.0083	0.0894	CbGeAlD
Hydroflumethiazide—CA2—collecting duct of renal tubule—kidney cancer	0.00635	0.0684	CbGeAlD
Hydroflumethiazide—SLC12A1—nephron—kidney cancer	0.00634	0.0683	CbGeAlD
Hydroflumethiazide—SLC12A1—urine—kidney cancer	0.00508	0.0547	CbGeAlD
Hydroflumethiazide—Epigastric discomfort—Everolimus—kidney cancer	0.00195	0.0277	CcSEcCtD
Hydroflumethiazide—SLC12A3—nephron tubule—kidney cancer	0.00179	0.0193	CbGeAlD
Hydroflumethiazide—CA7—renal system—kidney cancer	0.00166	0.0179	CbGeAlD
Hydroflumethiazide—SLC12A3—renal system—kidney cancer	0.00163	0.0175	CbGeAlD
Hydroflumethiazide—CA7—kidney—kidney cancer	0.00161	0.0173	CbGeAlD
Hydroflumethiazide—SLC12A3—kidney—kidney cancer	0.00158	0.017	CbGeAlD
Hydroflumethiazide—SLC12A3—cortex of kidney—kidney cancer	0.00153	0.0165	CbGeAlD
Hydroflumethiazide—SLC12A1—nephron tubule—kidney cancer	0.00137	0.0147	CbGeAlD
Hydroflumethiazide—SLC12A1—renal system—kidney cancer	0.00124	0.0134	CbGeAlD
Hydroflumethiazide—CA14—cardiac atrium—kidney cancer	0.00124	0.0134	CbGeAlD
Hydroflumethiazide—SLC12A1—kidney—kidney cancer	0.0012	0.013	CbGeAlD
Hydroflumethiazide—Bendroflumethiazide—KCNMA1—kidney cancer	0.00118	0.196	CrCbGaD
Hydroflumethiazide—SLC12A1—cortex of kidney—kidney cancer	0.00117	0.0126	CbGeAlD
Hydroflumethiazide—KCNMA1—renal system—kidney cancer	0.00113	0.0121	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Everolimus—kidney cancer	0.00111	0.0157	CcSEcCtD
Hydroflumethiazide—CA12—renal system—kidney cancer	0.00108	0.0116	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Everolimus—kidney cancer	0.00105	0.0148	CcSEcCtD
Hydroflumethiazide—CA12—kidney—kidney cancer	0.00104	0.0112	CbGeAlD
Hydroflumethiazide—KCNMA1—gonad—kidney cancer	0.00101	0.0109	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Sunitinib—kidney cancer	0.000925	0.0131	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Sunitinib—kidney cancer	0.000874	0.0124	CcSEcCtD
Hydroflumethiazide—CA5B—gonad—kidney cancer	0.000869	0.00936	CbGeAlD
Hydroflumethiazide—CA5B—cardiac atrium—kidney cancer	0.000868	0.00935	CbGeAlD
Hydroflumethiazide—CA1—renal system—kidney cancer	0.000856	0.00922	CbGeAlD
Hydroflumethiazide—CA1—kidney—kidney cancer	0.000827	0.00891	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—KCNMA1—kidney cancer	0.000818	0.136	CrCbGaD
Hydroflumethiazide—Pancreatitis—Pazopanib—kidney cancer	0.000801	0.0113	CcSEcCtD
Hydroflumethiazide—ATP1A1—nephron tubule—kidney cancer	0.000796	0.00858	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Vincristine—kidney cancer	0.000783	0.0111	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Temsirolimus—kidney cancer	0.000782	0.0111	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Dactinomycin—kidney cancer	0.000763	0.0108	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Pazopanib—kidney cancer	0.000745	0.0106	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Vincristine—kidney cancer	0.000739	0.0105	CcSEcCtD
Hydroflumethiazide—CA4—nephron tubule—kidney cancer	0.000736	0.00793	CbGeAlD
Hydroflumethiazide—ATP1A1—renal system—kidney cancer	0.000724	0.0078	CbGeAlD
Hydroflumethiazide—Jaundice—Pazopanib—kidney cancer	0.00071	0.0101	CcSEcCtD
Hydroflumethiazide—Vasculitis—Gemcitabine—kidney cancer	0.000706	0.01	CcSEcCtD
Hydroflumethiazide—ATP1A1—kidney—kidney cancer	0.0007	0.00754	CbGeAlD
Hydroflumethiazide—ATP1A1—cortex of kidney—kidney cancer	0.000682	0.00734	CbGeAlD
Hydroflumethiazide—CA4—renal system—kidney cancer	0.000669	0.00721	CbGeAlD
Hydroflumethiazide—ATP1A1—gonad—kidney cancer	0.000649	0.00699	CbGeAlD
Hydroflumethiazide—ATP1A1—cardiac atrium—kidney cancer	0.000648	0.00698	CbGeAlD
Hydroflumethiazide—CA4—kidney—kidney cancer	0.000647	0.00697	CbGeAlD
Hydroflumethiazide—Bendroflumethiazide—CA2—kidney cancer	0.000636	0.105	CrCbGaD
Hydroflumethiazide—Pancreatitis—Everolimus—kidney cancer	0.000632	0.00896	CcSEcCtD
Hydroflumethiazide—CA4—cortex of kidney—kidney cancer	0.00063	0.00678	CbGeAlD
Hydroflumethiazide—CA2—nephron tubule—kidney cancer	0.00061	0.00657	CbGeAlD
Hydroflumethiazide—Pancreatitis—Erlotinib—kidney cancer	0.00061	0.00865	CcSEcCtD
Hydroflumethiazide—CA4—cardiac atrium—kidney cancer	0.000599	0.00645	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Everolimus—kidney cancer	0.000582	0.00824	CcSEcCtD
Hydroflumethiazide—Jaundice—Everolimus—kidney cancer	0.00056	0.00794	CcSEcCtD
Hydroflumethiazide—Methyclothiazide—CA2—kidney cancer	0.000558	0.0925	CrCbGaD
Hydroflumethiazide—CA2—renal system—kidney cancer	0.000555	0.00597	CbGeAlD
Hydroflumethiazide—Pancreatitis—Sorafenib—kidney cancer	0.000549	0.00778	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Pazopanib—kidney cancer	0.000547	0.00775	CcSEcCtD
Hydroflumethiazide—Cyclothiazide—CA2—kidney cancer	0.000541	0.0897	CrCbGaD
Hydroflumethiazide—Leukopenia—Temsirolimus—kidney cancer	0.000541	0.00766	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Vinblastine—kidney cancer	0.000539	0.00763	CcSEcCtD
Hydroflumethiazide—Chlorothiazide—CA2—kidney cancer	0.000537	0.089	CrCbGaD
Hydroflumethiazide—CA2—kidney—kidney cancer	0.000536	0.00578	CbGeAlD
Hydroflumethiazide—Pancreatitis—Sunitinib—kidney cancer	0.000528	0.00748	CcSEcCtD
Hydroflumethiazide—CA2—cortex of kidney—kidney cancer	0.000522	0.00563	CbGeAlD
Hydroflumethiazide—Leukopenia—Pazopanib—kidney cancer	0.000509	0.00722	CcSEcCtD
Hydroflumethiazide—CA2—cardiac atrium—kidney cancer	0.000497	0.00535	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—CA9—kidney cancer	0.00049	0.0813	CrCbGaD
Hydroflumethiazide—Jaundice—Sorafenib—kidney cancer	0.000486	0.0069	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Sunitinib—kidney cancer	0.000486	0.00689	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Temsirolimus—kidney cancer	0.000483	0.00684	CcSEcCtD
Hydroflumethiazide—Anorexia—Temsirolimus—kidney cancer	0.00047	0.00666	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Pazopanib—kidney cancer	0.000455	0.00645	CcSEcCtD
Hydroflumethiazide—Anorexia—Pazopanib—kidney cancer	0.000443	0.00627	CcSEcCtD
Hydroflumethiazide—Hydrochlorothiazide—CA2—kidney cancer	0.000441	0.0731	CrCbGaD
Hydroflumethiazide—Trichlormethiazide—CA9—kidney cancer	0.000437	0.0725	CrCbGaD
Hydroflumethiazide—Muscle spasms—Everolimus—kidney cancer	0.000432	0.00612	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Temsirolimus—kidney cancer	0.000429	0.00607	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Dactinomycin—kidney cancer	0.000424	0.00601	CcSEcCtD
Hydroflumethiazide—Constipation—Temsirolimus—kidney cancer	0.000422	0.00598	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Vincristine—kidney cancer	0.000416	0.00589	CcSEcCtD
Hydroflumethiazide—Agitation—Everolimus—kidney cancer	0.000413	0.00585	CcSEcCtD
Hydroflumethiazide—Vertigo—Vinblastine—kidney cancer	0.000405	0.00574	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vinblastine—kidney cancer	0.000404	0.00572	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Pazopanib—kidney cancer	0.000404	0.00572	CcSEcCtD
Hydroflumethiazide—Leukopenia—Everolimus—kidney cancer	0.000402	0.0057	CcSEcCtD
Hydroflumethiazide—Trichlormethiazide—CA2—kidney cancer	0.000393	0.0652	CrCbGaD
Hydroflumethiazide—Photosensitivity—Capecitabine—kidney cancer	0.000391	0.00555	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Gemcitabine—kidney cancer	0.00039	0.00553	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Capecitabine—kidney cancer	0.000384	0.00544	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Paclitaxel—kidney cancer	0.000382	0.00542	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Paclitaxel—kidney cancer	0.000377	0.00534	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—kidney cancer	0.000377	0.00534	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Sorafenib—kidney cancer	0.000375	0.00531	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Temsirolimus—kidney cancer	0.000363	0.00515	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Sunitinib—kidney cancer	0.000361	0.00511	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vinblastine—kidney cancer	0.00036	0.00511	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Gemcitabine—kidney cancer	0.00036	0.0051	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Everolimus—kidney cancer	0.000359	0.00509	CcSEcCtD
Hydroflumethiazide—Purpura—Capecitabine—kidney cancer	0.000356	0.00505	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Paclitaxel—kidney cancer	0.000355	0.00503	CcSEcCtD
Hydroflumethiazide—Asthenia—Temsirolimus—kidney cancer	0.000354	0.00501	CcSEcCtD
Hydroflumethiazide—Anorexia—Vinblastine—kidney cancer	0.000351	0.00497	CcSEcCtD
Hydroflumethiazide—Anorexia—Everolimus—kidney cancer	0.00035	0.00495	CcSEcCtD
Hydroflumethiazide—Leukopenia—Sorafenib—kidney cancer	0.000349	0.00495	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—kidney cancer	0.000347	0.00492	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Erlotinib—kidney cancer	0.000346	0.00491	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Temsirolimus—kidney cancer	0.000337	0.00478	CcSEcCtD
Hydroflumethiazide—Anorexia—Erlotinib—kidney cancer	0.000337	0.00478	CcSEcCtD
Hydroflumethiazide—Leukopenia—Sunitinib—kidney cancer	0.000336	0.00476	CcSEcCtD
Hydroflumethiazide—Asthenia—Pazopanib—kidney cancer	0.000333	0.00472	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00033	0.00468	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—kidney cancer	0.000329	0.00466	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Paclitaxel—kidney cancer	0.000326	0.00463	CcSEcCtD
Hydroflumethiazide—Dizziness—Temsirolimus—kidney cancer	0.000326	0.00462	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinblastine—kidney cancer	0.00032	0.00454	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Everolimus—kidney cancer	0.000319	0.00452	CcSEcCtD
Hydroflumethiazide—Leukopenia—Dactinomycin—kidney cancer	0.000318	0.00451	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pazopanib—kidney cancer	0.000318	0.0045	CcSEcCtD
Hydroflumethiazide—Constipation—Vinblastine—kidney cancer	0.000315	0.00446	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Capecitabine—kidney cancer	0.000314	0.00445	CcSEcCtD
Hydroflumethiazide—Constipation—Everolimus—kidney cancer	0.000314	0.00444	CcSEcCtD
Hydroflumethiazide—Vomiting—Temsirolimus—kidney cancer	0.000313	0.00444	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Sorafenib—kidney cancer	0.000312	0.00442	CcSEcCtD
Hydroflumethiazide—Rash—Temsirolimus—kidney cancer	0.000311	0.00441	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—kidney cancer	0.000311	0.0044	CcSEcCtD
Hydroflumethiazide—Dermatitis—Temsirolimus—kidney cancer	0.000311	0.0044	CcSEcCtD
Hydroflumethiazide—Headache—Temsirolimus—kidney cancer	0.000309	0.00438	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Erlotinib—kidney cancer	0.000308	0.00436	CcSEcCtD
Hydroflumethiazide—Dizziness—Pazopanib—kidney cancer	0.000307	0.00435	CcSEcCtD
Hydroflumethiazide—Anorexia—Sorafenib—kidney cancer	0.000303	0.0043	CcSEcCtD
Hydroflumethiazide—Constipation—Erlotinib—kidney cancer	0.000303	0.00429	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Sunitinib—kidney cancer	0.0003	0.00425	CcSEcCtD
Hydroflumethiazide—Vomiting—Pazopanib—kidney cancer	0.000295	0.00419	CcSEcCtD
Hydroflumethiazide—Rash—Pazopanib—kidney cancer	0.000293	0.00415	CcSEcCtD
Hydroflumethiazide—Nausea—Temsirolimus—kidney cancer	0.000293	0.00415	CcSEcCtD
Hydroflumethiazide—Dermatitis—Pazopanib—kidney cancer	0.000293	0.00415	CcSEcCtD
Hydroflumethiazide—Anorexia—Sunitinib—kidney cancer	0.000292	0.00414	CcSEcCtD
Hydroflumethiazide—Agitation—Vincristine—kidney cancer	0.000292	0.00413	CcSEcCtD
Hydroflumethiazide—Headache—Pazopanib—kidney cancer	0.000291	0.00412	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—kidney cancer	0.000286	0.00406	CcSEcCtD
Hydroflumethiazide—Vertigo—Vincristine—kidney cancer	0.000285	0.00404	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vincristine—kidney cancer	0.000284	0.00403	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000284	0.00402	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Sorafenib—kidney cancer	0.000277	0.00392	CcSEcCtD
Hydroflumethiazide—Anorexia—Dactinomycin—kidney cancer	0.000276	0.00392	CcSEcCtD
Hydroflumethiazide—Nausea—Pazopanib—kidney cancer	0.000276	0.00391	CcSEcCtD
Hydroflumethiazide—Constipation—Sorafenib—kidney cancer	0.000272	0.00386	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinblastine—kidney cancer	0.000271	0.00384	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Capecitabine—kidney cancer	0.000271	0.00384	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Everolimus—kidney cancer	0.00027	0.00383	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gemcitabine—kidney cancer	0.00027	0.00382	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Capecitabine—kidney cancer	0.000268	0.0038	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Sunitinib—kidney cancer	0.000266	0.00377	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinblastine—kidney cancer	0.000264	0.00374	CcSEcCtD
Hydroflumethiazide—Asthenia—Everolimus—kidney cancer	0.000263	0.00373	CcSEcCtD
Hydroflumethiazide—Constipation—Sunitinib—kidney cancer	0.000262	0.00371	CcSEcCtD
Hydroflumethiazide—Jaundice—Capecitabine—kidney cancer	0.000258	0.00366	CcSEcCtD
Hydroflumethiazide—Asthenia—Erlotinib—kidney cancer	0.000254	0.0036	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vincristine—kidney cancer	0.000254	0.0036	CcSEcCtD
Hydroflumethiazide—Urticaria—Sorafenib—kidney cancer	0.000253	0.00358	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—kidney cancer	0.000252	0.00357	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Dactinomycin—kidney cancer	0.000252	0.00357	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinblastine—kidney cancer	0.000252	0.00357	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Everolimus—kidney cancer	0.000251	0.00356	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—kidney cancer	0.000248	0.00351	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Capecitabine—kidney cancer	0.000247	0.0035	CcSEcCtD
Hydroflumethiazide—Anorexia—Vincristine—kidney cancer	0.000247	0.0035	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinblastine—kidney cancer	0.000243	0.00345	CcSEcCtD
Hydroflumethiazide—Dizziness—Everolimus—kidney cancer	0.000242	0.00344	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Paclitaxel—kidney cancer	0.000242	0.00344	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Erlotinib—kidney cancer	0.000242	0.00343	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000241	0.00341	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Sorafenib—kidney cancer	0.000235	0.00332	CcSEcCtD
Hydroflumethiazide—Anorexia—Gemcitabine—kidney cancer	0.000234	0.00332	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinblastine—kidney cancer	0.000234	0.00332	CcSEcCtD
Hydroflumethiazide—Dizziness—Erlotinib—kidney cancer	0.000234	0.00332	CcSEcCtD
Hydroflumethiazide—Vomiting—Everolimus—kidney cancer	0.000233	0.0033	CcSEcCtD
Hydroflumethiazide—Agitation—Paclitaxel—kidney cancer	0.000232	0.00328	CcSEcCtD
Hydroflumethiazide—Rash—Everolimus—kidney cancer	0.000231	0.00328	CcSEcCtD
Hydroflumethiazide—Dermatitis—Everolimus—kidney cancer	0.000231	0.00327	CcSEcCtD
Hydroflumethiazide—Headache—Vinblastine—kidney cancer	0.000231	0.00327	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—kidney cancer	0.00023	0.00326	CcSEcCtD
Hydroflumethiazide—Headache—Everolimus—kidney cancer	0.00023	0.00326	CcSEcCtD
Hydroflumethiazide—Asthenia—Sorafenib—kidney cancer	0.000228	0.00324	CcSEcCtD
Hydroflumethiazide—Vertigo—Paclitaxel—kidney cancer	0.000226	0.00321	CcSEcCtD
Hydroflumethiazide—Leukopenia—Paclitaxel—kidney cancer	0.000226	0.0032	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Sunitinib—kidney cancer	0.000226	0.0032	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vincristine—kidney cancer	0.000225	0.00319	CcSEcCtD
Hydroflumethiazide—Vomiting—Erlotinib—kidney cancer	0.000225	0.00319	CcSEcCtD
Hydroflumethiazide—Rash—Erlotinib—kidney cancer	0.000223	0.00316	CcSEcCtD
Hydroflumethiazide—Dermatitis—Erlotinib—kidney cancer	0.000223	0.00316	CcSEcCtD
Hydroflumethiazide—Headache—Erlotinib—kidney cancer	0.000222	0.00314	CcSEcCtD
Hydroflumethiazide—Constipation—Vincristine—kidney cancer	0.000222	0.00314	CcSEcCtD
Hydroflumethiazide—Asthenia—Sunitinib—kidney cancer	0.00022	0.00311	CcSEcCtD
Hydroflumethiazide—Nausea—Vinblastine—kidney cancer	0.000219	0.0031	CcSEcCtD
Hydroflumethiazide—Nausea—Everolimus—kidney cancer	0.000218	0.00309	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Sorafenib—kidney cancer	0.000218	0.00309	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gemcitabine—kidney cancer	0.000214	0.00303	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Dactinomycin—kidney cancer	0.000214	0.00303	CcSEcCtD
Hydroflumethiazide—Dizziness—Sorafenib—kidney cancer	0.00021	0.00298	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—kidney cancer	0.00021	0.00298	CcSEcCtD
Hydroflumethiazide—Nausea—Erlotinib—kidney cancer	0.00021	0.00298	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Sunitinib—kidney cancer	0.00021	0.00297	CcSEcCtD
Hydroflumethiazide—Asthenia—Dactinomycin—kidney cancer	0.000208	0.00295	CcSEcCtD
Hydroflumethiazide—Dizziness—Sunitinib—kidney cancer	0.000203	0.00287	CcSEcCtD
Hydroflumethiazide—Vomiting—Sorafenib—kidney cancer	0.000202	0.00287	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000202	0.00287	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000201	0.00286	CcSEcCtD
Hydroflumethiazide—Rash—Sorafenib—kidney cancer	0.000201	0.00284	CcSEcCtD
Hydroflumethiazide—Dermatitis—Sorafenib—kidney cancer	0.0002	0.00284	CcSEcCtD
Hydroflumethiazide—Headache—Sorafenib—kidney cancer	0.000199	0.00283	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Capecitabine—kidney cancer	0.000199	0.00282	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Dactinomycin—kidney cancer	0.000198	0.00281	CcSEcCtD
Hydroflumethiazide—Anorexia—Paclitaxel—kidney cancer	0.000196	0.00278	CcSEcCtD
Hydroflumethiazide—Vomiting—Sunitinib—kidney cancer	0.000195	0.00276	CcSEcCtD
Hydroflumethiazide—Rash—Sunitinib—kidney cancer	0.000193	0.00274	CcSEcCtD
Hydroflumethiazide—Dermatitis—Sunitinib—kidney cancer	0.000193	0.00273	CcSEcCtD
Hydroflumethiazide—Headache—Sunitinib—kidney cancer	0.000192	0.00272	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vincristine—kidney cancer	0.000191	0.00271	CcSEcCtD
Hydroflumethiazide—Nausea—Sorafenib—kidney cancer	0.000189	0.00268	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—kidney cancer	0.000188	0.00266	CcSEcCtD
Hydroflumethiazide—Vertigo—Capecitabine—kidney cancer	0.000186	0.00263	CcSEcCtD
Hydroflumethiazide—Asthenia—Vincristine—kidney cancer	0.000186	0.00263	CcSEcCtD
Hydroflumethiazide—Leukopenia—Capecitabine—kidney cancer	0.000185	0.00263	CcSEcCtD
Hydroflumethiazide—Vomiting—Dactinomycin—kidney cancer	0.000184	0.00261	CcSEcCtD
Hydroflumethiazide—Rash—Dactinomycin—kidney cancer	0.000183	0.00259	CcSEcCtD
Hydroflumethiazide—Nausea—Sunitinib—kidney cancer	0.000182	0.00258	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Paclitaxel—kidney cancer	0.000179	0.00254	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vincristine—kidney cancer	0.000177	0.00251	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—kidney cancer	0.000176	0.0025	CcSEcCtD
Hydroflumethiazide—Constipation—Paclitaxel—kidney cancer	0.000176	0.00249	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000175	0.00248	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000173	0.00245	CcSEcCtD
Hydroflumethiazide—Nausea—Dactinomycin—kidney cancer	0.000172	0.00244	CcSEcCtD
Hydroflumethiazide—Dizziness—Vincristine—kidney cancer	0.000171	0.00243	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—kidney cancer	0.000168	0.00238	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—kidney cancer	0.000166	0.00236	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Capecitabine—kidney cancer	0.000165	0.00234	CcSEcCtD
Hydroflumethiazide—Vomiting—Vincristine—kidney cancer	0.000165	0.00233	CcSEcCtD
Hydroflumethiazide—Urticaria—Paclitaxel—kidney cancer	0.000163	0.00232	CcSEcCtD
Hydroflumethiazide—Rash—Vincristine—kidney cancer	0.000163	0.00232	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vincristine—kidney cancer	0.000163	0.00231	CcSEcCtD
Hydroflumethiazide—Headache—Vincristine—kidney cancer	0.000162	0.0023	CcSEcCtD
Hydroflumethiazide—Anorexia—Capecitabine—kidney cancer	0.000161	0.00228	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—kidney cancer	0.000159	0.00226	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—kidney cancer	0.000156	0.00221	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—kidney cancer	0.000155	0.0022	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—kidney cancer	0.000155	0.00219	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—kidney cancer	0.000154	0.00218	CcSEcCtD
Hydroflumethiazide—Nausea—Vincristine—kidney cancer	0.000154	0.00218	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Paclitaxel—kidney cancer	0.000152	0.00215	CcSEcCtD
Hydroflumethiazide—Asthenia—Paclitaxel—kidney cancer	0.000148	0.00209	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Capecitabine—kidney cancer	0.000147	0.00208	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—kidney cancer	0.000146	0.00207	CcSEcCtD
Hydroflumethiazide—Constipation—Capecitabine—kidney cancer	0.000144	0.00205	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Paclitaxel—kidney cancer	0.000141	0.002	CcSEcCtD
Hydroflumethiazide—Dizziness—Paclitaxel—kidney cancer	0.000136	0.00193	CcSEcCtD
Hydroflumethiazide—Urticaria—Capecitabine—kidney cancer	0.000134	0.0019	CcSEcCtD
Hydroflumethiazide—Vomiting—Paclitaxel—kidney cancer	0.000131	0.00185	CcSEcCtD
Hydroflumethiazide—Rash—Paclitaxel—kidney cancer	0.00013	0.00184	CcSEcCtD
Hydroflumethiazide—Dermatitis—Paclitaxel—kidney cancer	0.00013	0.00184	CcSEcCtD
Hydroflumethiazide—Headache—Paclitaxel—kidney cancer	0.000129	0.00183	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—kidney cancer	0.000128	0.00182	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Capecitabine—kidney cancer	0.000124	0.00176	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—kidney cancer	0.000123	0.00174	CcSEcCtD
Hydroflumethiazide—Nausea—Paclitaxel—kidney cancer	0.000122	0.00173	CcSEcCtD
Hydroflumethiazide—Asthenia—Capecitabine—kidney cancer	0.000121	0.00172	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—kidney cancer	0.00012	0.0017	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—kidney cancer	0.000119	0.00169	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Capecitabine—kidney cancer	0.000116	0.00164	CcSEcCtD
Hydroflumethiazide—Dizziness—Capecitabine—kidney cancer	0.000112	0.00158	CcSEcCtD
Hydroflumethiazide—Vomiting—Capecitabine—kidney cancer	0.000107	0.00152	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000107	0.00151	CcSEcCtD
Hydroflumethiazide—Rash—Capecitabine—kidney cancer	0.000106	0.00151	CcSEcCtD
Hydroflumethiazide—Dermatitis—Capecitabine—kidney cancer	0.000106	0.00151	CcSEcCtD
Hydroflumethiazide—Headache—Capecitabine—kidney cancer	0.000106	0.0015	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—kidney cancer	0.000104	0.00147	CcSEcCtD
Hydroflumethiazide—Nausea—Capecitabine—kidney cancer	0.0001	0.00142	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—kidney cancer	9.46e-05	0.00134	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—kidney cancer	9.31e-05	0.00132	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—kidney cancer	8.65e-05	0.00123	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—kidney cancer	8.02e-05	0.00114	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—kidney cancer	7.81e-05	0.00111	CcSEcCtD
Hydroflumethiazide—CA12—Metabolism—ALAD—kidney cancer	7.51e-05	0.000839	CbGpPWpGaD
Hydroflumethiazide—Diarrhoea—Doxorubicin—kidney cancer	7.45e-05	0.00106	CcSEcCtD
Hydroflumethiazide—CA7—Metabolism—SLC5A3—kidney cancer	7.42e-05	0.000828	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PGK1—kidney cancer	7.42e-05	0.000828	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PGK1—kidney cancer	7.42e-05	0.000828	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC5A3—kidney cancer	7.42e-05	0.000828	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ST3GAL2—kidney cancer	7.33e-05	0.000819	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA1—kidney cancer	7.33e-05	0.000818	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—LDHB—kidney cancer	7.27e-05	0.000812	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—LDHB—kidney cancer	7.27e-05	0.000812	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPAT—kidney cancer	7.23e-05	0.000807	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GLIPR1—kidney cancer	7.23e-05	0.000807	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD2—kidney cancer	7.2e-05	0.000804	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Doxorubicin—kidney cancer	7.2e-05	0.00102	CcSEcCtD
Hydroflumethiazide—CA9—Metabolism—PDHB—kidney cancer	7.17e-05	0.0008	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALDH1A1—kidney cancer	7.17e-05	0.0008	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.15e-05	0.000799	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.15e-05	0.000799	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GLIPR1—kidney cancer	6.93e-05	0.000774	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPAT—kidney cancer	6.93e-05	0.000774	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CA9—kidney cancer	6.93e-05	0.000774	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Doxorubicin—kidney cancer	6.92e-05	0.000981	CcSEcCtD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.91e-05	0.000771	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.91e-05	0.000771	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC5A3—kidney cancer	6.87e-05	0.000767	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PGK1—kidney cancer	6.87e-05	0.000767	CbGpPWpGaD
Hydroflumethiazide—Rash—Doxorubicin—kidney cancer	6.86e-05	0.000973	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—kidney cancer	6.86e-05	0.000972	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA2—kidney cancer	6.82e-05	0.000761	CbGpPWpGaD
Hydroflumethiazide—Headache—Doxorubicin—kidney cancer	6.82e-05	0.000967	CcSEcCtD
Hydroflumethiazide—CA9—Metabolism—CCBL1—kidney cancer	6.74e-05	0.000752	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—LDHB—kidney cancer	6.74e-05	0.000752	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—FH—kidney cancer	6.72e-05	0.000751	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APRT—kidney cancer	6.72e-05	0.000751	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPAT—kidney cancer	6.65e-05	0.000742	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GLIPR1—kidney cancer	6.65e-05	0.000742	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—BRAF—kidney cancer	6.52e-05	0.000727	CbGpPWpGaD
Hydroflumethiazide—Nausea—Doxorubicin—kidney cancer	6.46e-05	0.000916	CcSEcCtD
Hydroflumethiazide—CA2—Metabolism—FH—kidney cancer	6.44e-05	0.00072	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APRT—kidney cancer	6.44e-05	0.00072	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPC3—kidney cancer	6.32e-05	0.000706	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CA9—kidney cancer	6.31e-05	0.000704	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CA9—kidney cancer	6.31e-05	0.000704	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—FH—kidney cancer	6.18e-05	0.00069	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APRT—kidney cancer	6.18e-05	0.00069	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—kidney cancer	6.17e-05	0.000689	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CA2—kidney cancer	6.15e-05	0.000686	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IGF2—kidney cancer	6.14e-05	0.000685	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPC3—kidney cancer	6.06e-05	0.000677	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—HIF1A—kidney cancer	6.05e-05	0.000675	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.01e-05	0.000671	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALAD—kidney cancer	5.99e-05	0.000669	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—kidney cancer	5.97e-05	0.000666	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CRABP1—kidney cancer	5.89e-05	0.000658	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ST3GAL2—kidney cancer	5.85e-05	0.000653	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPAT—kidney cancer	5.84e-05	0.000652	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GLIPR1—kidney cancer	5.84e-05	0.000652	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CA9—kidney cancer	5.84e-05	0.000652	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPC3—kidney cancer	5.81e-05	0.000649	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALAD—kidney cancer	5.74e-05	0.000641	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALDH1A1—kidney cancer	5.72e-05	0.000638	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CA2—kidney cancer	5.65e-05	0.000631	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ST3GAL2—kidney cancer	5.61e-05	0.000626	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALAD—kidney cancer	5.51e-05	0.000615	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ITPR2—kidney cancer	5.48e-05	0.000612	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PGK1—kidney cancer	5.48e-05	0.000612	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC5A3—kidney cancer	5.48e-05	0.000612	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALDH1A1—kidney cancer	5.48e-05	0.000612	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.45e-05	0.000609	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.45e-05	0.000609	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—RAF1—kidney cancer	5.44e-05	0.000607	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APRT—kidney cancer	5.43e-05	0.000606	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—FH—kidney cancer	5.43e-05	0.000606	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ST3GAL2—kidney cancer	5.38e-05	0.0006	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—LDHB—kidney cancer	5.37e-05	0.0006	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CRABP1—kidney cancer	5.36e-05	0.000599	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CRABP1—kidney cancer	5.36e-05	0.000599	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALDH1A1—kidney cancer	5.25e-05	0.000587	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PGK1—kidney cancer	5.25e-05	0.000587	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC5A3—kidney cancer	5.25e-05	0.000587	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—LDHB—kidney cancer	5.15e-05	0.000575	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPC3—kidney cancer	5.11e-05	0.00057	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PGK1—kidney cancer	5.04e-05	0.000562	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC5A3—kidney cancer	5.04e-05	0.000562	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ACHE—kidney cancer	5e-05	0.000558	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTT1—kidney cancer	5e-05	0.000558	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ITPR2—kidney cancer	4.99e-05	0.000557	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ITPR2—kidney cancer	4.99e-05	0.000557	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CA2—kidney cancer	4.97e-05	0.000555	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CRABP1—kidney cancer	4.97e-05	0.000555	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—LDHB—kidney cancer	4.94e-05	0.000552	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALAD—kidney cancer	4.84e-05	0.000541	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SCARB1—kidney cancer	4.73e-05	0.000528	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ST3GAL2—kidney cancer	4.73e-05	0.000528	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS1—kidney cancer	4.68e-05	0.000523	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CA9—kidney cancer	4.66e-05	0.00052	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALDH1A1—kidney cancer	4.62e-05	0.000516	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ITPR2—kidney cancer	4.62e-05	0.000516	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PSMD7—kidney cancer	4.59e-05	0.000513	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTT1—kidney cancer	4.55e-05	0.000508	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTT1—kidney cancer	4.55e-05	0.000508	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ACHE—kidney cancer	4.55e-05	0.000508	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ACHE—kidney cancer	4.55e-05	0.000508	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CA9—kidney cancer	4.47e-05	0.000499	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PGK1—kidney cancer	4.43e-05	0.000494	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC5A3—kidney cancer	4.43e-05	0.000494	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—BCHE—kidney cancer	4.35e-05	0.000486	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—LDHB—kidney cancer	4.34e-05	0.000485	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	4.33e-05	0.000483	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SCARB1—kidney cancer	4.3e-05	0.00048	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SCARB1—kidney cancer	4.3e-05	0.00048	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SLC5A5—kidney cancer	4.3e-05	0.00048	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CA9—kidney cancer	4.28e-05	0.000478	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS1—kidney cancer	4.26e-05	0.000476	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS1—kidney cancer	4.26e-05	0.000476	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ACHE—kidney cancer	4.21e-05	0.00047	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTT1—kidney cancer	4.21e-05	0.00047	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PSMD7—kidney cancer	4.18e-05	0.000466	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PSMD7—kidney cancer	4.18e-05	0.000466	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—RELA—kidney cancer	4.16e-05	0.000465	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SLC2A1—kidney cancer	4.15e-05	0.000464	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MTOR—kidney cancer	4.08e-05	0.000456	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—kidney cancer	4.07e-05	0.000455	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SCARB1—kidney cancer	3.99e-05	0.000445	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CRABP1—kidney cancer	3.96e-05	0.000442	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—BCHE—kidney cancer	3.96e-05	0.000442	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—BCHE—kidney cancer	3.96e-05	0.000442	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS1—kidney cancer	3.95e-05	0.000441	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC5A5—kidney cancer	3.91e-05	0.000437	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SLC5A5—kidney cancer	3.91e-05	0.000437	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PSMD7—kidney cancer	3.87e-05	0.000432	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	3.83e-05	0.000428	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CRABP1—kidney cancer	3.8e-05	0.000424	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SLC2A1—kidney cancer	3.78e-05	0.000422	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC2A1—kidney cancer	3.78e-05	0.000422	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—MAPK1—kidney cancer	3.73e-05	0.000417	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ITPR2—kidney cancer	3.68e-05	0.000411	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—BCHE—kidney cancer	3.67e-05	0.00041	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—JUN—kidney cancer	3.65e-05	0.000407	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CRABP1—kidney cancer	3.64e-05	0.000407	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC5A5—kidney cancer	3.62e-05	0.000405	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ITPR2—kidney cancer	3.53e-05	0.000394	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC2A1—kidney cancer	3.5e-05	0.000391	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—kidney cancer	3.46e-05	0.000387	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.4e-05	0.000379	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ITPR2—kidney cancer	3.39e-05	0.000378	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—RAF1—kidney cancer	3.38e-05	0.000377	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ACHE—kidney cancer	3.36e-05	0.000375	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTT1—kidney cancer	3.36e-05	0.000375	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ABCB1—kidney cancer	3.28e-05	0.000366	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTT1—kidney cancer	3.22e-05	0.00036	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ACHE—kidney cancer	3.22e-05	0.00036	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CRABP1—kidney cancer	3.2e-05	0.000357	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.19e-05	0.000356	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTM1—kidney cancer	3.18e-05	0.000355	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SCARB1—kidney cancer	3.18e-05	0.000355	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—kidney cancer	3.15e-05	0.000352	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—kidney cancer	3.15e-05	0.000352	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS1—kidney cancer	3.15e-05	0.000351	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ACHE—kidney cancer	3.09e-05	0.000345	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—kidney cancer	3.09e-05	0.000345	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PSMD7—kidney cancer	3.09e-05	0.000345	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.09e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.09e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SCARB1—kidney cancer	3.05e-05	0.00034	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—kidney cancer	3.03e-05	0.000338	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS1—kidney cancer	3.02e-05	0.000337	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A1—kidney cancer	3.02e-05	0.000337	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK3—kidney cancer	3.01e-05	0.000337	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCB1—kidney cancer	2.98e-05	0.000333	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCB1—kidney cancer	2.98e-05	0.000333	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ITPR2—kidney cancer	2.98e-05	0.000332	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PSMD7—kidney cancer	2.96e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—BCHE—kidney cancer	2.93e-05	0.000327	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SCARB1—kidney cancer	2.92e-05	0.000326	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—kidney cancer	2.92e-05	0.000326	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—kidney cancer	2.9e-05	0.000323	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—kidney cancer	2.9e-05	0.000323	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS1—kidney cancer	2.89e-05	0.000323	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC5A5—kidney cancer	2.89e-05	0.000323	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.87e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PSMD7—kidney cancer	2.84e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—BCHE—kidney cancer	2.81e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A1—kidney cancer	2.79e-05	0.000312	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC5A5—kidney cancer	2.77e-05	0.000309	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCB1—kidney cancer	2.76e-05	0.000309	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A1—kidney cancer	2.75e-05	0.000307	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A1—kidney cancer	2.75e-05	0.000307	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ACHE—kidney cancer	2.71e-05	0.000303	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—kidney cancer	2.71e-05	0.000303	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—BCHE—kidney cancer	2.69e-05	0.0003	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—kidney cancer	2.68e-05	0.0003	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A1—kidney cancer	2.68e-05	0.000299	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC5A5—kidney cancer	2.66e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—kidney cancer	2.57e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SCARB1—kidney cancer	2.57e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A1—kidney cancer	2.57e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS1—kidney cancer	2.54e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A1—kidney cancer	2.54e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000278	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MAPK3—kidney cancer	2.44e-05	0.000272	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—kidney cancer	2.41e-05	0.000269	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—BCHE—kidney cancer	2.36e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC5A5—kidney cancer	2.34e-05	0.000261	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—kidney cancer	2.33e-05	0.00026	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MAPK1—kidney cancer	2.32e-05	0.000259	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A1—kidney cancer	2.26e-05	0.000252	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—POMC—kidney cancer	2.25e-05	0.000251	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—kidney cancer	2.23e-05	0.000249	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCB1—kidney cancer	2.2e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—kidney cancer	2.19e-05	0.000244	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—kidney cancer	2.14e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—kidney cancer	2.14e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCB1—kidney cancer	2.11e-05	0.000236	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—kidney cancer	2.05e-05	0.000229	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—POMC—kidney cancer	2.05e-05	0.000229	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—POMC—kidney cancer	2.05e-05	0.000229	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A1—kidney cancer	2.03e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCB1—kidney cancer	2.03e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—kidney cancer	2.01e-05	0.000225	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—kidney cancer	1.97e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—kidney cancer	1.95e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A1—kidney cancer	1.94e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—POMC—kidney cancer	1.9e-05	0.000212	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—kidney cancer	1.88e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A1—kidney cancer	1.86e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—kidney cancer	1.79e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCB1—kidney cancer	1.78e-05	0.000199	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—kidney cancer	1.73e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A1—kidney cancer	1.64e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—kidney cancer	1.63e-05	0.000182	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—kidney cancer	1.63e-05	0.000182	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—kidney cancer	1.56e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—kidney cancer	1.51e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—POMC—kidney cancer	1.51e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—POMC—kidney cancer	1.45e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—kidney cancer	1.42e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—kidney cancer	1.42e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—POMC—kidney cancer	1.39e-05	0.000155	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—kidney cancer	1.32e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—POMC—kidney cancer	1.22e-05	0.000136	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—kidney cancer	1.21e-05	0.000135	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—kidney cancer	1.16e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000124	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—kidney cancer	1.1e-05	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—kidney cancer	1.05e-05	0.000117	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—kidney cancer	1.01e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—kidney cancer	1e-05	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—kidney cancer	1e-05	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—kidney cancer	9.75e-06	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—kidney cancer	9.67e-06	0.000108	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—kidney cancer	9.3e-06	0.000104	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—kidney cancer	8.5e-06	9.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—kidney cancer	7.42e-06	8.29e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—kidney cancer	7.11e-06	7.94e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—kidney cancer	6.82e-06	7.62e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—kidney cancer	6e-06	6.69e-05	CbGpPWpGaD
